Endpoints Capital's funding for Recce Pharmaceuticals is a t...

Endpoints Capital's funding for Recce Pharmaceuticals is a testament to Recce's strong scientific platform and promising pipeline. The funding is expected to boost Recce's clinical programs and extend its financial runway.